Frank Greco

Oncology

250 25th Ave N Ste 100
Nashville, TN 37203

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Is It Time to Retire the Unified Cancer of Unknown Primary Concept in the Precision Oncology Era?

Is It Time to Retire the Unified Cancer of Unknown Primary Concept in the Precision Oncology Era?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 12, 2026

Implementing practice-changing progress for managing cancer of unknown primary.

Implementing practice-changing progress for managing cancer of unknown primary.

Journal: Nature reviews. Cancer

Published: September 24, 2025

Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art Perspective.

Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art Perspective.

Journal: Journal of personalized medicine

Published: September 11, 2025

Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor.

Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor.

Journal: Oncogene

Published: March 17, 2025

Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary.

Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary.

Journal: JCO precision oncology

Published: September 04, 2024

Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone.

Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone.

Journal: The Lancet. Oncology

Published: June 10, 2024

Molecular guided therapies: a practice-changing step forward in cancer of unknown primary management.

Molecular guided therapies: a practice-changing step forward in cancer of unknown primary management.

Journal: Lancet (London, England)

Published: April 21, 2024

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 23, 2023

Body composition imaging, clinicopathological status, and genetic profile in clear cell renal cell carcinoma.

Body composition imaging, clinicopathological status, and genetic profile in clear cell renal cell carcinoma.

Journal: Nigerian journal of clinical practice

Published: December 20, 2022

International consensus on the initial diagnostic workup of cancer of unknown primary.

International consensus on the initial diagnostic workup of cancer of unknown primary.

Journal: Critical reviews in oncology/hematology

Published: October 03, 2022

Systematic review of the CUP trials characteristics and perspectives for next-generation studies.

Systematic review of the CUP trials characteristics and perspectives for next-generation studies.

Journal: Cancer treatment reviews

Published: March 01, 2022

The need for validation of MI GPSai in patients with CUP: Comment on: "Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type" by J Abraham et al.

The need for validation of MI GPSai in patients with CUP: Comment on: "Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type" by J Abraham et al.

Journal: Translational oncology

Published: March 03, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026